Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1975 2
1976 2
1977 1
1978 6
1979 8
1980 20
1981 18
1982 21
1983 25
1984 69
1985 52
1986 46
1987 59
1988 54
1989 71
1990 71
1991 93
1992 79
1993 76
1994 61
1995 47
1996 54
1997 55
1998 52
1999 40
2000 49
2001 40
2002 40
2003 58
2004 52
2005 52
2006 36
2007 32
2008 37
2009 41
2010 42
2011 36
2012 45
2013 51
2014 36
2015 24
2016 28
2017 36
2018 42
2019 30
2020 33
2021 38
2022 36
2023 29
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

1,957 results

Results by year

Filters applied: . Clear all
Page 1
Propafenone.
Funck-Brentano C, Kroemer HK, Lee JT, Roden DM. Funck-Brentano C, et al. N Engl J Med. 1990 Feb 22;322(8):518-25. doi: 10.1056/NEJM199002223220806. N Engl J Med. 1990. PMID: 2405273 Review. No abstract available.
An open-label randomized noninferior study of generic name and brand name of propafenone for rhythm control in patients with paroxysmal atrial fibrillation.
Chin CG, Hsieh YC, Lin WS, Lin YJ, Chiou CW, Lin TH, Huang CL, Hung Y, Lin YK, Chang SL, Yeh TC, Lee HC, Lai WT, Hsieh MH. Chin CG, et al. J Chin Med Assoc. 2023 May 1;86(5):472-478. doi: 10.1097/JCMA.0000000000000903. Epub 2023 Feb 17. J Chin Med Assoc. 2023. PMID: 36800262 Clinical Trial.
BACKGROUND: Propafenone is a class IC antiarrhythmic agent that is commonly used as the first-line therapy for patients with paroxysmal atrial fibrillation (AF) in Taiwan. This study compared the efficacy and safety of generic (Rhynorm) and brand name (Rytmonorm) …
BACKGROUND: Propafenone is a class IC antiarrhythmic agent that is commonly used as the first-line therapy for patients with paroxysm …
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study).
Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S; ERAFT Investigators. Meinertz T, et al. Am J Cardiol. 2002 Dec 15;90(12):1300-6. doi: 10.1016/s0002-9149(02)02867-9. Am J Cardiol. 2002. PMID: 12480038 Clinical Trial.
The median arrhythmia-free time was 9 days in the placebo group, 35 days in the propafenone SR 325 mg twice daily group, and 44 days in the propafenone SR 425 mg twice daily group. ...The percentage of patients with >/=1 serious adverse event was similar in the …
The median arrhythmia-free time was 9 days in the placebo group, 35 days in the propafenone SR 325 mg twice daily group, and 44 days …
Propafenone.
Veale D, McComb JM, Gibson GJ. Veale D, et al. Lancet. 1990 Apr 21;335(8695):979. doi: 10.1016/0140-6736(90)91048-f. Lancet. 1990. PMID: 1970054 No abstract available.
[Propafenone poisoning].
Sadeg N, Richecoeur J, Dumontet M. Sadeg N, et al. Therapie. 2003 Jul-Aug;58(4):381-3; discussion 387. doi: 10.2515/therapie:2003061. Therapie. 2003. PMID: 14679682 French. No abstract available.
Atrial fibrillation (acute onset).
Lip GY, Watson T. Lip GY, et al. BMJ Clin Evid. 2008 May 2;2008:0210. BMJ Clin Evid. 2008. PMID: 19450312 Free PMC article. Review.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: amiodarone, antithrombotic treatment before cardioversion, digoxin, diltiazem, direct current cardioversion, flecainide, propafenone, quin …
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: amiod …
Propafenone-induced psoriasis.
Palleschi GM, Bellandi S, Torchia D. Palleschi GM, et al. Clin Exp Dermatol. 2008 Mar;33(2):209-10. doi: 10.1111/j.1365-2230.2007.02671.x. Clin Exp Dermatol. 2008. PMID: 18257839 No abstract available.
[Persistent atrial flutter induced by propafenone (Rytmonorm)].
Fazekas T, Kiss J, Pap I, Rudas L. Fazekas T, et al. Orv Hetil. 1994 Aug 14;135(33):1819-22. Orv Hetil. 1994. PMID: 8072758 Hungarian.
The case history of two patients with atrial fibrillation are presented. In order to prevent/terminate fibrillation propafenone (Rytmonorm, 450-600 mg/day) was started, however this therapy resulted in permanent atrial flutter of 230-270/min mainly with 2:1 antriove …
The case history of two patients with atrial fibrillation are presented. In order to prevent/terminate fibrillation propafenone (R
1,957 results